Aytu Bioscience Stock News

Is (AYTU) Outperforming Other Medical Stocks This Year?

SINGAPORE (THE BUSINESS TIMES) - The following companies saw new developments that may affect trading of their securities on Monday (June 29):. Read more at straitstimes.com.

THE following companies saw new developments that may affect trading of their securities on Monday: Read more at The Business Times.

Aytu Bioscience, Inc. (AYTU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).

ASLAN Pharmaceuticals (ASLN) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Q3 2020 Aytu BioScience Inc Earnings Call

Aclaris Therapeutics (NASDAQ:ACRS) and Aytu Bioscience (NASDAQ:AYTU) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strengt

On Monday,  shares of Aytu BioScience, Inc. (NASDAQ:AYTU) reached at $1.51 price level during last trade its distance from 20 days simple moving average was [...]

The

Between December 2019 and March 2020, Aytu had issued almost 100M shares which diluted existing shareholders 81%. Throughout this dilution, Aytu has grown reven

Is (AYTU) Outperforming Other Medical Stocks This Year?

bluebird (BLUE) reports new phase III data on betibeglogene autotemcel in TDT.

The

Aytu BioScience (AYTU) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Ultragenyx's (RARE) shares rise more than 60% year to date on various positive pipeline developments.